China Medical Device & Pharma International Collaboration Acceleration Center Launches in Berlin to Propel Chinese Healthcare Innovation Globalization

On October 15, 2025, at the 2025 China (Chengdu)–Berlin Economic and Trade Cooperation Matchmaking Conference held in Berlin, Germany, the China Medical and Pharmaceutical Industry International Cooperation Acceleration Center was officially established through a signing ceremony. Under the guidance of the Chengdu Municipal Bureau of Expo Affairs and the Chengdu International Chamber of Commerce, the center was jointly initiated by VCBeat Europe Center and Sichuan Silk Road E-Commerce Technology Co., Ltd., aiming to promote the global expansion of China’s pharmaceutical and medical device industries and to build new channels for industrial collaboration and innovative development between China and foreign countries.

As China’s first internationalization service agency for the healthcare and pharmaceutical industry, centered on a media platform and supported by databases, the Acceleration Center will build an end-to-end overseas expansion service system covering R&D, production, trade, and communication through its “Two Databases, One Platform” model. The “Two Databases” enable precise matchmaking by establishing a producer database encompassing approximately 180,000 Chinese healthcare and pharmaceutical companies, alongside a global resource repository of distributors, agents, investment institutions, and clinical organizations, thereby achieving efficient supply-demand alignment. The “One Platform” empowers trust by leveraging VCBeat’s global communication and research ecosystem to create an integrated international service platform that combines data analytics, brand promotion, and partnership facilitation, helping industrial collaborations achieve tangible results.

VCBeat Europe and Silk Road E-Commerce Technology Company will establish Berlin as the core hub to connect innovation resources across Europe and globally, building an international healthcare industry cooperation network. Leveraging its strengths in communication and research within the global health technology sector, the Center will promote pragmatic exchanges and collaborative development among industries through economic and trade partnerships, academic collaborations, and industrial park initiatives.

Since its establishment in 2014, VCBeat has been deeply engaged in the medical technology industry for 11 years, accumulating over 600 in-depth industry research reports. It has continuously organized a series of branded events, including the “Medical Device Global Expansion Conference,” “China Biotech Overseas Financing Training,” and the “Innovative Overseas Healthcare List.” Furthermore, VCBeat has established long-term cooperative relationships with embassies and consulates from multiple countries, investment promotion agencies, and industry associations, thereby providing a solid foundation of knowledge and trust for the construction of the acceleration center.

Sichuan Silk Road Easy Buy Technology Co., Ltd. is a subsidiary of Sichuan Luhai Cloud Port Investment Group. As a national high-tech enterprise under Sichuan Provincial Port and Shipping Investment Group, it specializes in comprehensive foreign trade services integrating “technology + platform + service,” committed to promoting Sichuan’s open development, international industrial cooperation, and the expansion of Sichuan-made products beyond the province.

The launch of the China Medical Device Industry International Cooperation Acceleration Center marks a new phase in medical and pharmaceutical industry collaboration between Chengdu and Europe, injecting new momentum into the internationalization of China’s healthcare industry.